Vaishalee P Kenkre

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 7

Top Topics

Cell Cycle Arrest

Induced Apoptosis

Inflammatory Response

Hodgkin Lymphoma

Top Venues

Science (New York, N.Y.)

This page only lists publications with an associated author ORCID identifier.

Publications

Jaroslav Zak, Isaraphorn Pratumchai, Brett S Marro, Kristi L Marquardt, Reza Beheshti Zavareh, Luke L Lairson, Michael B A Oldstone, Judith A Varner, Livia Hegerova, Qing Cao, Umar Farooq, Vaishalee P Kenkre, Veronika Bachanova, John R Teijaro
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma. Science (New York, N.Y.) 384 (6702) (2024)
Jaroslav Zak, Isaraphorn Pratumchai, Brett S Marro, Kristi L Marquardt, Reza Beheshti Zavareh, Luke L Lairson, Michael B A Oldstone, Judith A Varner, Livia Hegerova, Qing Cao, Umar Farooq, Vaishalee P Kenkre, Veronika Bachanova, John R Teijaro
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma. Science (New York, N.Y.) 384 (6702) (2024)
Jaroslav Zak, Isaraphorn Pratumchai, Brett S Marro, Kristi L Marquardt, Reza Beheshti Zavareh, Luke L Lairson, Michael B A Oldstone, Judith A Varner, Livia Hegerova, Qing Cao, Umar Farooq, Vaishalee P Kenkre, Veronika Bachanova, John R Teijaro
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma. Science (New York, N.Y.) 384 (6702) (2024)
Jaroslav Zak, Isaraphorn Pratumchai, Brett S Marro, Kristi L Marquardt, Reza Beheshti Zavareh, Luke L Lairson, Michael B A Oldstone, Judith A Varner, Livia Hegerova, Qing Cao, Umar Farooq, Vaishalee P Kenkre, Veronika Bachanova, John R Teijaro
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma. Science (New York, N.Y.) 384 (6702) (2024)
Jaroslav Zak, Isaraphorn Pratumchai, Brett S Marro, Kristi L Marquardt, Reza Beheshti Zavareh, Luke L Lairson, Michael B A Oldstone, Judith A Varner, Livia Hegerova, Qing Cao, Umar Farooq, Vaishalee P Kenkre, Veronika Bachanova, John R Teijaro
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma. Science (New York, N.Y.) 384 (6702) (2024)
Jaroslav Zak, Isaraphorn Pratumchai, Brett S Marro, Kristi L Marquardt, Reza Beheshti Zavareh, Luke L Lairson, Michael B A Oldstone, Judith A Varner, Livia Hegerova, Qing Cao, Umar Farooq, Vaishalee P Kenkre, Veronika Bachanova, John R Teijaro
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma. Science (New York, N.Y.) 384 (6702) (2024)
Jaroslav Zak, Isaraphorn Pratumchai, Brett S Marro, Kristi L Marquardt, Reza Beheshti Zavareh, Luke L Lairson, Michael B A Oldstone, Judith A Varner, Livia Hegerova, Qing Cao, Umar Farooq, Vaishalee P Kenkre, Veronika Bachanova, John R Teijaro
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma. Science (New York, N.Y.) 384 (6702) (2024)